5th InterAmerican Oncology Conference

“Current Status and Future of Anti-Cancer Targeted Therapies”
10-11 October, 2013

Conference Chairmen

Román Perez Soler, New York, USA
Carlos L. Arteaga, Nashville, USA

Under the Auspices of

Academia Nacional de Medicina
Asociación Médica Argentina
Chemotherapy Foundation, USA
Sociedad Argentina de Cancerología
Sociedad Argentina de Hematología
Sociedad Argentina de Urología
Sociedade Brasileira de Oncologia Clinica
Sociedad Chilena de Cancerología
Sociedad Chilena de Hematología
Sociedad Colombiana de Hematología y Oncología
Sociedad de Medicina Interna de Buenos Aires
Sociedad Peruana de Oncologia Médica
Sociedad Venezolana de Oncología
Declared of special scientific interest by Facultad de Medicina, University of Buenos Aires


Alex A. Adjei, M.D., Ph.D.
Professor and Chair, Department of Medicine
Katherine Anne Gioia Chair in Cancer Medicine
Roswell Park Cancer Institute
Buffalo, NY, USA

Kenneth C. Anderson, M.D.
Kraft Family Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts, USA

Carlos L. Arteaga, M.D.
Professor of Medicine and Cancer Biology
Associate Director for Clinical Research
Director, Breast Cancer Program
Vanderbilt –Ingram Cancer Center
Nashville, Tennessee, USA

Joaquim Bellmunt M.D., Ph.D.
NAQAA Professor of Medicine
Pompeu Fabra University
Section Chief, Solid Tumor Oncology (GU & GI)
Medical Oncology Service, Hospital del Mar
Barcelona, Spain

Robert L. Coleman, M.D.
Professor & Vice Chair, Clinical Research
Department of Gynecologic Oncology & Reproductive Medicine
M.D. Anderson Cancer Center
Houston, Texas, USA

Jorge Cortés, M.D.
Professor of Medicine
Chief, CML & AML Sections
Deputy Chair, Department of Leukemia
M.D. Anderson Cancer Center
Houston, Texas, USA

Hernán Cortés Funes, M.D.
Department of Medical Oncology
Hospital Universitario “12 de Octubre”
Madrid, Spain

John P. Leonard, M.D.
Richard T. Silver Distinguished Professor
of Hematology and Medical Oncology
Associate Dean for Clinical Research
Chief, Lymphoma Service,
Vice Chairman for Clinical Research
Weill Cornell Cancer Center
New York, New York, USA

Román Pérez-Soler, M.D.
Chairman, Department of Oncology
Montefiore Medical Center
Albert Einstein College of Medicine
Bronx, New York, USA

Daniel P. Petrylak, M.D.
Director, Genitourinary Oncology Program
Co Director, Signal Transduction Program
Yale University Cancer Center
New Haven, Connecticut, USA

Jeffrey A. Sosman M.D.
Professor of Medicine
Ingram Professor for Cancer Research
Vanderbilt University Medical Center
Division of Hematology/Oncology
Nashville, Tennessee, USA

Josep Tabernero, M.D.
Chairman Medical Oncology Department
Vall d’Hebron University Hospital
Barcelona, Spain

Vicente Valero, M.D., F.A.C.P.
Chairman, Ad Interim
Department of Breast Medical Oncology
M.D. Anderson Cancer Center
Houston, Texas, USA

John J. Wright, M.D., Ph.D.
Associate Branch Chief
Investigational Drug Branch
National Cancer Institute
Bethesda, Maryland, USA


The supporting companies have no control over the selection of the faculty or the content of the presentations.


bayerBoehringer Ingelheimcelgene-logomsd oncologia




pierre fabre